Wojtowicz-Praga S. Clinical potential of matrix metalloprotease inhibitors.
Drugs R D (New Zealand). 1999;1:117-129.
Dupont E, Savard PE, Jourdain C, et al. Antiangiogenic properties of a novel shark cartilage extract: Potential role in the treatment of psoriasis.
J Cutan Med Surg. 1998;2:146-152.
Prudden JF, Nishihara G, Baker L. The acceleration of wound healing with cartilage-I.
Surg Gynecol Obstet.
1957;105:283-287.
Dupont E, Savard PE, Jourdain C, et al. Antiangiogenic properties of a novel shark cartilage extract: Potential role in the treatment of psoriasis.
J Cutan Med Surg. 1998;2:146-152.
Sheu JR, Fu CC, Tsai ML, et al. Effect of U-995, a potent shark cartilage-derived angiogenesis inhibitor, on anti-angiogenesis and anti-tumor activities.
Anticancer Res. 1998;18:4435-4441.
Davis PF, He Y, Furneaux RH, et al. Inhibition of angiogenesis by oral ingestion of powdered shark cartilage in a rat model.
Microvasc Res. 1997;54:178-182.
Oikawa T, Ashino-Fuse H, Shimamura M, et al. A novel angiogenic inhibitor derived from Japanese shark cartilage (I). Extraction and estimation of inhibitory activities toward tumor and embryonic angiogenesis.
Cancer Lett.
1990;51:181-186.
McGuire TR, Kazakoff PW, Hoie EB, et al. Antiproliferative activity of shark cartilage with and without tumor necrosis factor-alpha in human umbilical vein endothelium.
Pharmacotherapy.
1996;16:237-244.
Lee A, Langer R. Shark cartilage contains inhibitors of tumor angiogenesis.
Science.
1983;221:1185-1187.
Riviere M, Latreille J, Falardeau P, et al. AE-941 (Neovastat), an inhibitor of angiogenesis: phase I/II cancer clinical trial results.
Cancer Invest. 1999;17(suppl 1):16-17.
Jamali M-A, Riviere M, Falardeau P, et al. Effect of AE-941 (neovastat), an angiogenesis inhibitor, in the Lewis lung carcinoma metastatic model, efficacy, toxicity prevention and survival.
Clin Invest Med. 1998;(suppl):S16.
Riviere M, Falardeau P, Latreille J, et al. Phase I/II lung cancer clinical trial results with AE-941 (neovastat), an inhibitor of angiogenesis.
Clin Invest Med. 1998;(suppl):S14.
Riviere M, Alaoui-Jamali M, Falardeau P, et al. Neovastat: an inhibitor of angiogenesis with anti-cancer activity. Presented at: American Association for Cancer Research Annual Meeting 39; March 28-April 1, 1998; New Orleans, LA.
Blasecki J, Alaoui-Jamali M, Wang T, et al. Oral administration of Neovastat inhibits tumor progression in animal models of progressive tumor growth and metastasis.
Int J Oncol. 1997;11(suppl):934.
Dupont E, Alaoui-Jamali M, Wang T, et al. Angiostatic and antitumoral activity of AE-941 (Neovastat), a molecular fraction derived from shark cartilage. Presented at: American Association for Cancer Research Annual Meeting 38; April 12-16, 1997; San Diego, CA.
Horsman MR, Alsner J, Overgaard J. The effect of shark cartilage extracts on the growth and metastatic spread of the SCCVII carcinoma.
Acta Oncol.
1998;37:441-445.
Miller DR, Anderson GT, Stark JJ, et al. Phase I/II trial of the safety and efficacy of shark cartilage in the treatment of advanced cancer.
J Clin Oncol.
1998;16:3649-3655.
Ashar B, Vargo E. Shark cartilage-induced hepatitis.
Ann Intern Med.
1996;125:780-781.
Loprinzi C, Levitt R, Barton DL, et al. Evaluation of shark cartilage in patients with advanced cancer.
Cancer. 2005 May 23.
Sussman, L. Shark cartilage shows no benefit as a therapeutic agent for lung cancer. EurekAlert! website. Available at:
http://www.eurekalert.org/pub_releases/2007-06...tm-scs060107.php. Accessed June 19, 2007.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.